David J. Greenblatt - Publications, H-index & Citations

David J. Greenblatt

tufts university

107H指数

1.1K论文数

4.6W被引数

收录论文 124

发表时间

Incomplete Data and Potential Risks of Drugs in People with Obesity

CURRENT OBESITY REPORTS

IF11

2023-11-18

OAAI

Apovian, Caroline M.; Bruno, Christopher D.; Kyle, Theodore K.; Chow, Christina R.; Greenblatt, David J.

Designer benzodiazepines: an update

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2023-01-27

PREAI

Yu, Xiao; Greenblatt, H. Karl; Greenblatt, David J.

Effect of lipophilicity on drug distribution and elimination: Influence of obesity

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2021-02-16

OAAI

Bruno, Christopher D.; Harmatz, Jerold S.; Duan, Su X.; Zhang, Qingchen; Chow, Christina R.; Greenblatt, David J.

Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years Old

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-10-01

OAAI

Enimil, Anthony; Antwi, Sampson; Yang, Hongmei; Dompreh, Albert; Alghamdi, Wael A.; Gillani, Fizza S.; Orstin, Antoinette; Bosomtwe, Dennis; Opoku, Theresa; Norman, Jennifer; Wiesner, Lubbe; Langaee, Taimour; Peloquin, Charles A.; Court, Michael H.; Greenblatt, David J.; Kwara, Awewura

Public Health Risk of Designer Psychotropic Drugs: Should PHASE Be Phased In?

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2019-08-22

PREAI

Greenblatt, David J.

Erythromycin acts through the ghrelin receptor to attenuate inflammatory responses in chondrocytes and maintain joint integrity

BIOCHEMICAL PHARMACOLOGY

IF5.6

2019-07-01

OAAI

Uchimura, Tomoya; Nakamura, Daisy S.; Link, Eric M.; Noguchi, Yoshihiko; Omura, Satoshi; Sunazuka, Toshiaki; Greenblatt, David J.; Zeng, Li

Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-01-01

OAAI

Kwara, Awewura; Yang, Hongmei; Antwi, Sampson; Enimil, Anthony; Gillani, Fizza S.; Dompreh, Albert; Ortsin, Antoinette; Opoku, Theresa; Bosomtwe, Dennis; Sarfo, Anima; Wiesner, Lubbe; Norman, Jennifer; Alghamdi, Wael A.; Langaee, Taimour; Peloquin, Charles A.; Court, Michael H.; Greenblatt, David J.

International Task Force on Benzodiazepines

PSYCHOTHERAPY AND PSYCHOSOMATICS

IF17.4

2018-05-22

OAAI

Balon, Richard; Chouinard, Guy; Cosci, Fiammetta; Dubovsky, Steven L.; Fava, Giovanni A.; Freire, Rafael C.; Greenblatt, David J.; Krystal, John H.; Nardi, Antonio E.; Rickels, Karl; Roth, Thomas; Salzman, Carl; Shader, Richard; Silberman, Edward K.; Sonino, Nicoletta; Starcevic, Vladan; Weintraub, Steven J.

Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study

CLINICAL THERAPEUTICS

IF3.6

2018-01-01

OAAI

Johnson-Agbakwu, Crista; Brown, Louise; Yuan, James; Kissling, Robert; Greenblatt, David J.

Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2017-09-01

OAAI

Court, Michael H.; Zhu, Zhaohui; Masse, Gina; Duan, Su X.; James, Laura P.; Harmatz, Jerold S.; Greenblatt, David J.

A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression 美新律在ALS中的随机试验: 安全性和对肌肉痉挛和进展的影响

NEUROLOGY

IF8.5

2016-04-19

OAAI

Weiss, Michael D.; Macklin, Eric A.; Simmons, Zachary; Knox, Angela S.; Greenblatt, David J.; Atassi, Nazem; Graves, Michael; Parziale, Nicholas; Salameh, Johnny S.; Quinn, Colin; Brown, Robert H.; Distad, Jane B.; Trivedi, Jaya; Shefner, Jeremy M.; Barohn, Richard J.; Pestronk, Alan; Swenson, Andrea; Cudkowicz, Merit E.

Favipiravir inhibits acetaminophen sulfate formation but minimally affects systemic pharmacokinetics of acetaminophen Favipiravir抑制硫酸对乙酰氨基酚的形成，但对对乙酰氨基酚的全身药代动力学影响最小

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2015-06-08

OAAI

Zhao, Yanli; Harmatz, Jerold S.; Epstein, Carol R.; Nakagawa, Yukako; Kurosaki, Chie; Nakamura, Tetsuro; Kadota, Takumi; Giesing, Dennis; Court, Michael H.; Greenblatt, David J.

Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2015-06-01

OAAI

Greenblatt, David J.; Harmatz, Jerold S.

AGE DOES NOT ALTER ACETAMINOPHEN ABSORPTION

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2015-04-27

PREAI

DIVOLL, M; AMEER, B; ABERNETHY, DR; GREENBLATT, DJ

PHYSIOLOGIC CHANGES IN OLD-AGE - RELATION TO ALTERED DRUG DISPOSITION

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2015-04-27

PREAI

GREENBLATT, DJ; DIVOLL, M; ABERNETHY, DR; SHADER, RI

CIMETIDINE IMPAIRS CLEARANCE OF ANTIPYRINE AND DESMETHYLDIAZEPAM IN THE ELDERLY

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2015-04-27

PREAI

DIVOLL, M; GREENBLATT, DJ; ABERNETHY, DR; SHADER, RI

Adverse performance effects of acute lorazepam administration in elderly long-term users: Pharmacokinetic and clinical predictors

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2015-01-01

OAAI

Pomara, Nunzio; Lee, Sang Han; Bruno, Davide; Silber, Timothy; Greenblatt, David J.; Petkova, Eva; Sidtis, John J.

Pharmacokinetics of Zolpidem from Sublingual Zolpidem Tartrate Tablets In Healthy Elderly Versus Non-Elderly Subjects

DRUGS & AGING

IF3.8

2014-09-23

PREAI

Greenblatt, David J.; Harmatz, Jerold S.; Singh, Nikhilesh N.; Steinberg, Frank; Roth, Thomas; Harris, Stephen C.; Kapil, Ram P.

Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction between Efavirenz and Antituberculosis Drug Therapy through Mechanism-Based Inactivation of CYP2A6

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2014-07-01

OAAI

Court, Michael H.; Almutairi, Fawziah E.; Greenblatt, David J.; Hazarika, Suwagmani; Sheng, Hongyan; Klein, Kathrin; Zanger, Ulrich M.; Bourgea, Joanne; Patten, Christopher J.; Kwara, Awewura

In Vitro Prediction of Clinical Drug Interactions With CYP3A Substrates: We Are Not There Yet

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2014-02-01

PREAI

Greenblatt, D. J.

研究方向